Tamás S. T.
- Country
- Hungary
- Department
- N/A
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Evaluation of Intracoronary AB-1002 Efficacy and Safety in NYHA Class III Non-Ischemic Cardiomyopathy
- Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Data & Insights
Has run more than one trial at 89 of 550 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating patients with non-ischemic cardiomyopathy and advanced heart failure conditions, with particular emphasis on NYHA Class III congestive heart failure.
- Heart Failure Management
- Cardiomyopathy Treatment
- Advanced Cardiac Care
Their clinical interests center on innovative therapeutic approaches for managing cardiac conditions.
Gene Therapy Applications
The investigator focuses on exploring novel gene therapy approaches in cardiovascular medicine, specifically investigating intracoronary delivery methods for cardiac conditions.
- Cardiac Gene Therapy
- Intracoronary Administration
- Therapeutic Innovation
Their work involves evaluating advanced therapeutic solutions for heart failure patients.
Clinical Therapeutics
The investigator's expertise encompasses the development and evaluation of targeted cardiovascular treatments, particularly focusing on interventional approaches for heart failure.
- Therapeutic Assessment
- Cardiovascular Interventions
- Treatment Efficacy
Their research emphasizes innovative therapeutic strategies for cardiac conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.